id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0027-0077,FDA,FDA-1978-N-0027,Skin Protectant Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment,Notice,Correction,2004-08-19T04:00:00Z,2004,8,2004-08-18T04:00:00Z,,2019-08-01T13:38:09Z,04-18975,0,0,0900006480560e47
FDA-1978-N-0027-0076,FDA,FDA-1978-N-0027,"Petition Approval Response Letter from FDA/Office of the Commissioner to The Cosmetic, Toiletry & Fragrance Association",Other,Approval,2004-02-26T05:00:00Z,2004,2,,,2019-06-04T13:29:10Z,,0,0,0900006480560e43
FDA-1978-N-0027-0075,FDA,FDA-1978-N-0027,Skin Protectant Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment,Notice,Notice of Final Rule,2003-12-09T05:00:00Z,2003,12,2003-12-09T05:00:00Z,2004-02-10T04:59:59Z,2019-08-01T14:04:49Z,03-30394,0,0,0900006480560e40
FDA-1978-N-0027-0074,FDA,FDA-1978-N-0027,"Acknowledgment Letter from FDA to Petition for Reconsideration from The Cosmetic, Toiletry & Fragrance Association",Other,Acknowledgement Letter/Receipt,2003-07-10T04:00:00Z,2003,7,,,2019-06-04T12:38:22Z,,0,0,0900006480560e32
FDA-1978-N-0027-0073,FDA,FDA-1978-N-0027,"Acknowledgment Letter from FDA to Petition for Reconsideration from The Cosmetic, Toiletry & Fragrance Association",Other,Acknowledgement Letter/Receipt,2003-07-10T04:00:00Z,2003,7,,,2019-06-03T20:24:34Z,,0,0,0900006480560e30
FDA-1978-N-0027-0069,FDA,FDA-1978-N-0027,Tab I.9: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T14:55:09Z,,0,0,0900006480560df8
FDA-1978-N-0027-0015,FDA,FDA-1978-N-0027,Tab V.22: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:38:07Z,,0,0,0900006480560cf8
FDA-1978-N-0027-0022,FDA,FDA-1978-N-0027,Tab P.16: Letter from FDA to The United States Pharmacopeial Convention Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:39:02Z,,0,0,0900006480560d0d
FDA-1978-N-0027-0036,FDA,FDA-1978-N-0027,Tab B: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:41:02Z,,0,0,0900006480560d3f
FDA-1978-N-0027-0059,FDA,FDA-1978-N-0027,Tab Y: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:44:11Z,,0,0,0900006480560ddc
FDA-1978-N-0027-0058,FDA,FDA-1978-N-0027,Tab X: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:44:04Z,,0,0,0900006480560dae
FDA-1978-N-0027-0072,FDA,FDA-1978-N-0027,Skin Protectant Drug Products for Over The Counter Human Use; Final,Notice,Notice of Final Rule,2003-06-13T04:00:00Z,2003,6,2003-06-04T04:00:00Z,2003-09-03T03:59:59Z,2019-08-01T15:33:43Z,03-13751,0,0,0900006480560e22
FDA-1978-N-0027-0010,FDA,FDA-1978-N-0027,Tab LL.38: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:37:23Z,,0,0,0900006480560cf1
FDA-1978-N-0027-0012,FDA,FDA-1978-N-0027,Tab S.19: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:37:41Z,,0,0,0900006480560cf3
FDA-1978-N-0027-0019,FDA,FDA-1978-N-0027,Tab Z.26: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:38:35Z,,0,0,0900006480560d04
FDA-1978-N-0027-0024,FDA,FDA-1978-N-0027,Tab BB.28: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:39:20Z,,0,0,0900006480560d13
FDA-1978-N-0027-0025,FDA,FDA-1978-N-0027,Tab CC.29: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:39:28Z,,0,0,0900006480560d15
FDA-1978-N-0027-0037,FDA,FDA-1978-N-0027,Tab C: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:41:10Z,,0,0,0900006480560d41
FDA-1978-N-0027-0040,FDA,FDA-1978-N-0027,Tab F: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:41:32Z,,0,0,0900006480560d77
FDA-1978-N-0027-0042,FDA,FDA-1978-N-0027,Tab H: Letter from FDA to Warner Lambert Company Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:41:48Z,,0,0,0900006480560d7d
FDA-1978-N-0027-0046,FDA,FDA-1978-N-0027,Tab L: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:42:21Z,,0,0,0900006480560d89
FDA-1978-N-0027-0023,FDA,FDA-1978-N-0027,Tab Q.17: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:39:12Z,,0,0,0900006480560d10
FDA-1978-N-0027-0066,FDA,FDA-1978-N-0027,Tab F.6: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:45:11Z,,0,0,0900006480560def
FDA-1978-N-0027-0006,FDA,FDA-1978-N-0027,Tab L.12: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:36:53Z,,0,0,0900006480560ced
FDA-1978-N-0027-0020,FDA,FDA-1978-N-0027,Tab AA.27: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:38:43Z,,0,0,0900006480560d07
FDA-1978-N-0027-0033,FDA,FDA-1978-N-0027,Table of Contents Re: Skin Protectant Drug Products for Over The Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:40:38Z,,0,0,0900006480560d2b
FDA-1978-N-0027-0048,FDA,FDA-1978-N-0027,Tab N: Letter of Acknowledgment from FDA to Revlon Health Care Group Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Rule,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:42:36Z,,0,0,0900006480560d8f
FDA-1978-N-0027-0056,FDA,FDA-1978-N-0027,Tab V: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:43:48Z,,0,0,0900006480560da7
FDA-1978-N-0027-0014,FDA,FDA-1978-N-0027,Tab U.21: Letter from FDA to Whitehall Laboratories Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:37:58Z,,0,0,0900006480560cf5
FDA-1978-N-0027-0057,FDA,FDA-1978-N-0027,Tab W: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:43:56Z,,0,0,0900006480560daa
FDA-1978-N-0027-0008,FDA,FDA-1978-N-0027,Tab N.14: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:37:13Z,,0,0,0900006480560cef
FDA-1978-N-0027-0032,FDA,FDA-1978-N-0027,Tab KK.37: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:40:29Z,,0,0,0900006480560d28
FDA-1978-N-0027-0035,FDA,FDA-1978-N-0027,Tab A: Subject- Citizen Petition on Aveeno Products Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:40:55Z,,0,0,0900006480560d3d
FDA-1978-N-0027-0039,FDA,FDA-1978-N-0027,Tab E: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:41:25Z,,0,0,0900006480560d74
FDA-1978-N-0027-0049,FDA,FDA-1978-N-0027,Tab O: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:42:44Z,,0,0,0900006480560d91
FDA-1978-N-0027-0051,FDA,FDA-1978-N-0027,Tab Q: Letter from Chesebrough Ponds Inc. to FDA Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:43:07Z,,0,0,0900006480560d98
FDA-1978-N-0027-0028,FDA,FDA-1978-N-0027,Tab GG.33: Letter from FDA to The United States PharmaCopeial Convention Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:39:52Z,,0,0,0900006480560d1e
FDA-1978-N-0027-0053,FDA,FDA-1978-N-0027,Tab S: Minutes of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:43:23Z,,0,0,0900006480560da0
FDA-1978-N-0027-0017,FDA,FDA-1978-N-0027,Tab X.24: Letter from FDA to The United States Pharmacopeial Convention Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-05T17:23:55Z,,0,0,0900006480560cfd
FDA-1978-N-0027-0052,FDA,FDA-1978-N-0027,Tab R: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:43:15Z,,0,0,0900006480560d9b
FDA-1978-N-0027-0021,FDA,FDA-1978-N-0027,Tab O.15: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:38:51Z,,0,0,0900006480560d09
FDA-1978-N-0027-0045,FDA,FDA-1978-N-0027,Tab K: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:42:12Z,,0,0,0900006480560d86
FDA-1978-N-0027-0055,FDA,FDA-1978-N-0027,Tab U: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:43:41Z,,0,0,0900006480560da4
FDA-1978-N-0027-0061,FDA,FDA-1978-N-0027,Tab A.1: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:44:27Z,,0,0,0900006480560de2
FDA-1978-N-0027-0067,FDA,FDA-1978-N-0027,Tab G.7: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:45:20Z,,0,0,0900006480560df2
FDA-1978-N-0027-0005,FDA,FDA-1978-N-0027,Tab K.11: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:36:41Z,,0,0,0900006480560cec
FDA-1978-N-0027-0013,FDA,FDA-1978-N-0027,Tab T.20: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:37:49Z,,0,0,0900006480560cf4
FDA-1978-N-0027-0031,FDA,FDA-1978-N-0027,Tab JJ.36: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:40:20Z,,0,0,0900006480560d26
FDA-1978-N-0027-0034,FDA,FDA-1978-N-0027,Tab 1.0: Correspondence & Memoranda Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:40:46Z,,0,0,0900006480560d3a
FDA-1978-N-0027-0044,FDA,FDA-1978-N-0027,Tab J: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:42:04Z,,0,0,0900006480560d82
FDA-1978-N-0027-0062,FDA,FDA-1978-N-0027,Tab B.2: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:44:39Z,,0,0,0900006480560de5
FDA-1978-N-0027-0011,FDA,FDA-1978-N-0027,Tab R.18: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:37:31Z,,0,0,0900006480560cf2
FDA-1978-N-0027-0016,FDA,FDA-1978-N-0027,Tab W.23: Letter from FDA to Joseph Deutsch Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:38:14Z,,0,0,0900006480560cfc
FDA-1978-N-0027-0026,FDA,FDA-1978-N-0027,Tab EE.31: Letter from FDA to David Buddrus M.D. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:39:36Z,,0,0,0900006480560d18
FDA-1978-N-0027-0030,FDA,FDA-1978-N-0027,Tab II.35: Letter from FDA to The Andrews Jergens Company Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:40:09Z,,0,0,0900006480560d23
FDA-1978-N-0027-0038,FDA,FDA-1978-N-0027,"Tab D: Letter from FDA to Church and Dwight Co., Inc. Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph",Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:41:18Z,,0,0,0900006480560d70
FDA-1978-N-0027-0071,FDA,FDA-1978-N-0027,Skin Protectant Drug Products for Over The Counter Human Use; Final,Notice,Notice of Final Rule,2003-06-13T04:00:00Z,2003,6,2003-06-04T04:00:00Z,2003-09-03T03:59:59Z,2019-08-01T15:28:54Z,03-13751,0,0,0900006480560e1d
FDA-1978-N-0027-0007,FDA,FDA-1978-N-0027,Tab M.13:  Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:37:00Z,,0,0,0900006480560cee
FDA-1978-N-0027-0018,FDA,FDA-1978-N-0027,Tab Y.25: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:38:27Z,,0,0,0900006480560d01
FDA-1978-N-0027-0041,FDA,FDA-1978-N-0027,Tab G: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:41:41Z,,0,0,0900006480560d7a
FDA-1978-N-0027-0060,FDA,FDA-1978-N-0027,Tab Z: Memo Record of Lubriderm Drug Labeling Claim Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:44:19Z,,0,0,0900006480560de0
FDA-1978-N-0027-0027,FDA,FDA-1978-N-0027,Tab FF.32: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:39:43Z,,0,0,0900006480560d1b
FDA-1978-N-0027-0047,FDA,FDA-1978-N-0027,Tab M: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:42:28Z,,0,0,0900006480560d8b
FDA-1978-N-0027-0050,FDA,FDA-1978-N-0027,Tab P: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:43:00Z,,0,0,0900006480560d93
FDA-1978-N-0027-0065,FDA,FDA-1978-N-0027,Tab E.5: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:45:02Z,,0,0,0900006480560dee
FDA-1978-N-0027-0068,FDA,FDA-1978-N-0027,Tab H.8: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:45:28Z,,0,0,0900006480560df6
FDA-1978-N-0027-0064,FDA,FDA-1978-N-0027,Tab D.4: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:44:53Z,,0,0,0900006480560deb
FDA-1978-N-0027-0029,FDA,FDA-1978-N-0027,Tab HH.34: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:40:01Z,,0,0,0900006480560d21
FDA-1978-N-0027-0043,FDA,FDA-1978-N-0027,Tab I: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:41:55Z,,0,0,0900006480560d80
FDA-1978-N-0027-0054,FDA,FDA-1978-N-0027,Tab T: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:43:30Z,,0,0,0900006480560da1
FDA-1978-N-0027-0063,FDA,FDA-1978-N-0027,Tab C.3: Memorandum of Meeting Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:44:46Z,,0,0,0900006480560de8
FDA-1978-N-0027-0070,FDA,FDA-1978-N-0027,Tab J.10: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:45:40Z,,0,0,0900006480560e1a
FDA-1978-N-0027-0009,FDA,FDA-1978-N-0027,Tab DD.30: Memorandum of Telephone Conversation Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Supporting & Related Material,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-05T17:22:38Z,,0,0,0900006480560cf0
FDA-1978-N-0027-0004,FDA,FDA-1978-N-0027,Antifungal Drug Products for Over-The-Counter Human Use; External Analgesic Drug Products for Over-The-Counter Human Use; Skin Protectant Drug Products for Over-The-Counter Human Use; and Topical Antimicrobial Drug Products for Over-The-Counter Human Use; Reopening of Administrative Records,Proposed Rule,Notice of Proposed Rulemaking (NPRM),1997-11-21T05:00:00Z,1997,11,1997-11-19T05:00:00Z,1998-02-18T04:59:59Z,2019-08-01T15:43:51Z,97-30410,0,0,0900006480560ce9
FDA-1978-N-0027-0003,FDA,FDA-1978-N-0027,Talc; Consumer Uses and Health Perspectives; Public Meetings,Notice,General Notice,1994-01-31T05:00:00Z,1994,1,1994-01-14T05:00:00Z,1994-03-03T04:59:59Z,2019-08-01T14:55:18Z,94-1083,0,0,0900006480560ccb